摘要
| 原文 | 英語 |
|---|---|
| 頁（從 - 到） | 365-369 |
| 頁數 | 5 |
| 期刊 | Journal of Laparoendoscopic and Advanced Surgical Techniques |
| 卷 | 28 |
| 發行號 | 4 |
| DOIs | |
| 出版狀態 | 已發佈 - 四月 1 2018 |
指紋
ASJC Scopus subject areas
- Surgery
引用此文
Transanal Total Mesorectal Excision in Lower Rectal Cancer : Comparison of Short-Term Outcomes with Conventional Laparoscopic Total Mesorectal Excision. / Chang, Tung Cheng; Kiu, Kee Thai.
於: Journal of Laparoendoscopic and Advanced Surgical Techniques, 卷 28, 編號 4, 01.04.2018, p. 365-369.研究成果: 雜誌貢獻 › 文章
}
TY - JOUR
T1 - Transanal Total Mesorectal Excision in Lower Rectal Cancer
T2 - Comparison of Short-Term Outcomes with Conventional Laparoscopic Total Mesorectal Excision
AU - Chang, Tung Cheng
AU - Kiu, Kee Thai
PY - 2018/4/1
Y1 - 2018/4/1
N2 - Background: Transanal total mesorectal excision (TaTME) is a novel technique to treat rectal cancer and also to obtain good-quality specimens. This study investigated the clinical results and perioperative and pathological outcomes of TaTME in lower rectal cancer treatment in comparison with laparoscopic total mesorectal excision (LaTME). Methods: During January 2014 to May 2017, all consecutive patients with lower rectal cancer who underwent TaTME were identified. This cohort study was matched for age, gender, American Society of Anesthesiology (ASA) score, and clinical staging with a cohort of patients who underwent conventional LaTME. Results: A total of 46 patients were analyzed in both groups. There were no significant differences in baseline characteristics between the groups. The estimated blood loss, duration of operation, and postoperative complications were also not different between both groups. Regarding pathological outcomes, no patients with circumferential margin (CRM) <1 mm were observed in the TaTME group compared to 4 patients with CRM <1 mm in the LaTME group (P = .037). Conclusion: TaTME is a safe and feasible procedure in this matched case-control study. TaTME had better pathological outcomes with CRM uninvolvement compared with laparoscopic surgery.
AB - Background: Transanal total mesorectal excision (TaTME) is a novel technique to treat rectal cancer and also to obtain good-quality specimens. This study investigated the clinical results and perioperative and pathological outcomes of TaTME in lower rectal cancer treatment in comparison with laparoscopic total mesorectal excision (LaTME). Methods: During January 2014 to May 2017, all consecutive patients with lower rectal cancer who underwent TaTME were identified. This cohort study was matched for age, gender, American Society of Anesthesiology (ASA) score, and clinical staging with a cohort of patients who underwent conventional LaTME. Results: A total of 46 patients were analyzed in both groups. There were no significant differences in baseline characteristics between the groups. The estimated blood loss, duration of operation, and postoperative complications were also not different between both groups. Regarding pathological outcomes, no patients with circumferential margin (CRM) <1 mm were observed in the TaTME group compared to 4 patients with CRM <1 mm in the LaTME group (P = .037). Conclusion: TaTME is a safe and feasible procedure in this matched case-control study. TaTME had better pathological outcomes with CRM uninvolvement compared with laparoscopic surgery.
KW - laparoscopy
KW - rectal cancer
KW - TME
KW - transanal
UR - http://www.scopus.com/inward/record.url?scp=85045332308&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85045332308&partnerID=8YFLogxK
U2 - 10.1089/lap.2017.0520
DO - 10.1089/lap.2017.0520
M3 - Article
AN - SCOPUS:85045332308
VL - 28
SP - 365
EP - 369
JO - Journal of Laparoendoscopic and Advanced Surgical Techniques - Part A
JF - Journal of Laparoendoscopic and Advanced Surgical Techniques - Part A
SN - 1092-6429
IS - 4
ER -